PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: the MUNICON phase II trial
Technical University of Munich · Klinikum rechts der Isar · +1 more institution
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
806
total citations
- FWCI
- 53.54
- Percentile
- 100%
- References
- 46
Citations per year
Authors
16- FLFlorian LordickCorresponding
Technical University of Munich, Klinikum rechts der Isar
- KOKatja Ott
Technical University of Munich, Klinikum rechts der Isar
- BKBernd‐Joachim Krause
Technical University of Munich, Klinikum rechts der Isar
- WWWolfgang Weber
Technical University of Munich, Klinikum rechts der Isar
- KBKaren Becker
Technical University of Munich, Klinikum rechts der Isar
Topics & keywords
Topics
Keywords
- Folinic acid
- Medicine
- Adenocarcinoma
- Cisplatin
- Fluorouracil
- Chemotherapy
- Internal medicine
- Clinical endpoint
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.